IL-6 has dual roles as both an anti-inflammatory and proinflammatory mediator, and its serum levels are enhanced in patients with hemorrhagic fevers of various viral origins, such as dengue hemorrhagic fever/shock syndrome, CCHF, Hantaan virus infection in patients with hemorrhagic fever with renal syndrome, and Ebola24–28. Here, IL6 is linked to hemorrhagic fever.